Clinical Trials Directory

Trials / Terminated

TerminatedNCT00764582

Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery

A Randomized, Observer-masked, Parallel-group, Multicenter Trial Evaluating the Ocular Penetration of 1.5% Levofloxacin Ophthalmic Solution and 0.5% Moxifloxacin Ophthalmic Solution in Subjects Undergoing Corneal Transplant Surgery

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Santen Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing penetrating keratoplasty (PK)

Conditions

Interventions

TypeNameDescription
DRUG1.5% levofloxacin ophthalmic solutionTopical application Instill 1 drop two times, 5 minutes apart. Time from last drop to surgery is determined by group. Group 1: 30 minutes prior to surgery Group 2: 1 hour prior to surgery Group 3: 2 hours prior to surgery Group 4: 4 hours prior to surgery
DRUG0.5% moxifloxacin ophthalmic solutionTopical application Instill 1 drop two times, 5 minutes apart. Time from last drop to surgery is determined by group. Group 5: 30 minutes prior to surgery Group 6: 1 hour prior to surgery Group 7: 2 hours prior to surgery Group 8: 4 hours prior to surgery

Timeline

Start date
2008-09-01
Primary completion
2009-03-01
First posted
2008-10-02
Last updated
2009-08-26

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00764582. Inclusion in this directory is not an endorsement.